To The Moon

$Pfizer(PFE)$

$Pfizer Inc. (PFE) +1.57% Rebounds from Support, Testing $26.5 Resistance as Momentum Builds 🚀

Latest Close Data: PFE closed at $25.81 on Aug 6, gaining +1.57% with a 2.01% amplitude. The stock is trading 10.2% below its 52-week high of $28.75, but firmly above the crucial $24.76 support floor.

Core Market Drivers: 🩺 The healthcare giant is showing resilience despite a lack of fresh catalysts today. The stock previously erased early gains on Aug 4 amid profit-taking, but the broader defensive sector rotation is providing a bid. The massive 6.67% dividend yield continues to anchor institutional interest, with BlackRock holding 8.74% of shares.

Technical Analysis: 📊 A bullish signal is flashing as the MACD histogram expands; the DIF line (0.136) has crossed decisively above the DEA line (0.016), confirming a new buy signal. The 6-day RSI has surged to 76.18, entering overbought territory and signaling intense short-term momentum. Volume was elevated at 47.05M shares today, validating the breakout attempt.

Key Price Levels: 🎯 Primary Support: $24.76 (recent swing low). Strong Resistance: $26.50 (immediate ceiling and key level to break). Immediate Pivot: $25.50. A close above $26.50 is critical to negate the bearish bias and target the 52-week highs.

Valuation Perspective: 💰 With a TTM P/E ratio of 19.66, PFE trades at a premium to its depressed historical forward P/E, but the P/S ratio of 2.30 and P/B of 1.72 remain reasonable for a pharma leader. The Forward P/E of 8.59 is significantly below the 10.33 average, hinting at undervaluation relative to future earnings.

Analyst Targets: 🏦 Among 32 analysts, the consensus rating is a Hold (5 Strong Buy, 6 Buy, 19 Hold, 1 Underperform, 1 Sell). The average price target of $28.61 suggests a +10.8% upside potential, with a high target of $35.46.

Weekly Outlook: The trend is turning bullish. Expect a consolidation between $25.50 and $26.50. A breakout above $26.50 resistance could trigger a rapid rally toward the $28.00–$28.75 zone. A failure to hold $25.50 invalidates the setup, risking a retest of the $24.76 support.

⚠️ Disclaimer: This is not financial advice. Trading involves substantial risk. Past performance is not indicative of future results. Always conduct your own research.

🎯$Pfizer Inc. (PFE) Options Strategy: Bull Call Spread (Debit Spread)

• Underlying: PFE (Pfizer Inc.)

• View: Cautiously Bullish / Momentum Continuation

• Strategy Type: Debit Spread / Directional

• Option Contract Portfolio:

  • Buy 1 PFE Aug 14, 2026 $25.50 Call @ $0.51 (Ask)

  • Sell 1 PFE Aug 14, 2026 $26.50 Call @ $0.11 (Bid)

• Max Gain & Loss:

  • Max Gain: $0.60 (Width of $1.00 - Debit $0.40). Achieved if PFE > $26.50 at expiration.

  • Max Loss: $0.40 (Net Debit paid). Incurred if PFE < $25.50 at expiration.

• Initial Cost/Credit: $0.40 Net Debit (per share).